Mueller StaphASeptic Bactericide Gel Mini Packs
Prevents skin infections caused by antibiotic-resistant staph (MRSA) and other germs. Parents, school administrators, coaches and kids need to be aware of the growing problem of antibiotic resistant germs including methicillin resistant staph (MRSA) because they spread easily from person to person and are appearing at epidemic rates. MRSA can spread through: Close skin-to-skin contact Cuts in the skin Contaminated surfaces and equipment Poor personal hygiene.
Community-acquired MRSA (CA-MRSA) is difficult to determine source of contact and spreads quickly, especially through young athletes who share contaminated equipment. Commonly used topical antibiotics, including popular triple antibiotics, have not been shown to prevent MRSA infections and can cause skin irritation in nearly 10% of the population. In vitro studies have shown that StaphAseptic® kills over 99.9% of MRSA germs, preventing an infection without antibiotics. This new pain-relieving wound treatment should be used as part of a complete staph prevention program to protect you and your family from skin infections. Active Ingredients - Benzethonium Chloride 0.2% (First Aid Antiseptic)
- Lidocaine HCI 2.5% (Topical Pain Reliever)
Inactive Ingredients - aminomethyl propanol
- allantoin
- carbomer
- cocamide DEA
- disodium EDTA
- glycerine
- polyoxl 35 castor oil
- purified water
- tea tree oil
- white thyme oil
|